Many pharma companies chase advanced AI without solving the foundational challenge of data integration. With only 10% of firms having unified data, true personalization is impossible until a central data platform is established to break down the typical 100+ data silos.

Electronic Health Record (EHR) companies have historically used proprietary formats to lock in customers. AI's ability to read and translate unstructured data from any source effectively breaks these data silos, finally making patient data truly portable.

Advanced AI models are ineffective in clinical settings without a robust data layer. Ambience had to solve fundamental problems like pulling messy context from inconsistent EHRs and preserving 'decision traces,' which are often destroyed by existing systems with mutable data structures.

Long before the AI boom, Novonesis began creating structured data repositories in the 2000s to manage high-throughput screening data. This decades-long data discipline is now a massive competitive advantage, providing the clean foundation necessary for effective machine learning and digital twins.

A major hurdle for enterprise AI is messy, siloed data. A synergistic solution is emerging where AI software agents are used for the data engineering tasks of cleansing, normalization, and linking. This creates a powerful feedback loop where AI helps prepare the very data it needs to function effectively.

In SaaS, value was delivered through visible UI. With AI, this is inverted. The most critical, differentiating work happens in the invisible infrastructure—complex RAG systems and custom models. The UI becomes the smaller, easier part of the product, flipping the traditional value proposition.

Simply adding an AI layer on top of a traditional SaaS stack will fail. A true AI-native architecture requires an "AI data layer" sitting next to the "AI application layer," both controlled by ML engineers who need to constantly tune data ingestion and processing without dependencies on the core tech team.

While many AI tools see low adoption (~20%), Ambience wins enterprise deals by demonstrating over 75% of clinicians use its product daily for 80%+ of visits. This high, sticky utilization is a crucial proof point that resonates with health system leaders and proves the tool's indispensability.

Using a composable, 'plug and play' architecture allows teams to build specialized AI agents faster and with less overhead than integrating a monolithic third-party tool. This approach enables the creation of lightweight, tailored solutions for niche use cases without the complexity of external API integrations, containing the entire workflow within one platform.